Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 28 | 1 | 27 | 0 |
| Shares | 739.4K | 5.14K | 743.0K | +8.70K (+1.2%) |
| Value | $5.80M | $40.3K | $5.01M | −$750.0K (−13.0%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Fortis Group Advisors, LLC | 14 | $94 | 0.00% |
| Comerica Bank | 1 | $7 | 0.00% |
| NBC Securities, Inc. | 33 | $0 | 0.00% |
Sold out (3)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Dorsey Wright & Associates | 2,555 | $20.0K |
| Tower Research Capital LLC (TRC) | 147 | $1.15K |
| Bank of America Corp | 1 | $8 |
Not filed for Q3 2023 yet (1)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 5,143 | $40.3K |